Meeting
2014 Breast Cancer Symposium
Efficacy of subcutaneous testosterone on menopausal symptoms in breast cancer survivors.
Authors
Rebecca L. Glaser
Department of Surgery, Wright State University, Dayton, OH
Rebecca L. Glaser , Anne E. York , Constantine Dimitrakakis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Local/Regional Therapy, Survivorship, and Health Policy
Track
Local/Regional Therapy,Survivorship and Health Policy
Sub Track
Survivorship
Citation
J Clin Oncol 32, 2014 (suppl 26; abstr 109)
DOI
10.1200/jco.2014.32.26_suppl.109
Abstract #
109
Poster Bd #
D2
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Use of intravaginal 17-β estradiol to improve sexual function and menopausal symptoms in postmenopausal women with breast cancer on aromatase inhibitors.
First Author: Shari Beth Goldfarb
Poster
2018 ASCO Annual Meeting
Efficacy of omega-3 (ω3) supplementation versus omega-6 (ω6) supplementation for reducing pain among breast cancer survivors: A URCC NCORP RCT.
First Author: Luke Joseph Peppone
Poster
2018 ASCO Annual Meeting
Ultra-low doses of TX-004HR to improve symptoms of vulvar and vaginal atrophy (VVA) while maintaining serum levels of estradiol within the normal postmenopausal range.
First Author: Shari Beth Goldfarb
Poster
2014 ASCO Annual Meeting
Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast cancer: An analysis of the prospective ABCSG-12 trial.
First Author: Georg Pfeiler